Other Kidney Diseases

Beyond acute kidney injury and polycystic kidney disease, the MNP technology platform may be used for the development of targeted therapeutics to treat other underserved renal tubule disorders, such as:

  • Cystinuria
  • Renal tubular acidosis
  • Lysinuric protein intolerance
  • Adenine-phosphoribosyl-transferase deficiency
  • Dent disease

In addition, Goldilocks is exploring approaches to target the glomerulus, which would open up the possibility to address an even wider range of kidney diseases.